Susquehanna Portfolio Strategies’s Editas Medicine EDIT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$822K	Buy	332,933 +88,578	+36%	+$187K	0.01%	670
2025 Q4	$501K	Sell	244,355 -63,979	-21%	-$185K	0.01%	781
2025 Q3	$1.07M	Buy	+308,334	New	+$861K	0.02%	670
2024 Q3	–	Sell	-110,972	Closed	-$518K	–	400
2024 Q2	$518K	Sell	110,972 -71,701	-39%	-$404K	0.02%	358
2024 Q1	$1.36M	Sell	182,673 -10,515	-5%	-$87.4K	0.03%	400
2023 Q4	$1.96M	Buy	+193,188	New	+$1.7M	0.03%	435

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna Portfolio Strategies's EDIT Position: Q1 2026 in Review

Susquehanna Portfolio Strategies increased its Editas Medicine (EDIT) stake by 36% in Q1 2026, buying an estimated $187K and bringing the position to 332,933 shares worth $822K. The position accounts for 0.01% of the portfolio, ranked #670.

Susquehanna Portfolio Strategies first reported a position in EDIT in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.96M in Q4 2023. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Susquehanna Portfolio Strategies held 332,933 shares of Editas Medicine worth $822K as of Q1 2026.
Susquehanna Portfolio Strategies bought 88,578 Editas Medicine shares in Q1 2026, an estimated $187K.
Editas Medicine made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #670 holding.
Susquehanna Portfolio Strategies first reported a position in Editas Medicine in Q4 2023 and has held it in 6 quarters since.
Susquehanna Portfolio Strategies's Editas Medicine position peaked at $1.96M in Q4 2023.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.